Menu Search
Equities

Lincoln National Corp

LNC:NYQ

Lincoln National Corp

Actions
FinancialsLife Insurance
  • Price (USD)35.71
  • Today's Change0.37 / 1.05%
  • Shares traded1.13m
  • 1 Year change+48.42%
  • Beta1.7725
Data delayed at least 15 minutes, as of Nov 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform0
Hold12
Sell1
Strong Sell0

Share price forecast in USD

The 10 analysts offering 12 month price targets for Lincoln National Corp have a median target of 36.00, with a high estimate of 45.00 and a low estimate of 29.00. The median estimate represents a 1.87% increase from the last price of 35.34.
High27.3%45.00
Med1.9%36.00
Low-17.9%29.00

Dividends in USD

In 2023, Lincoln National Corp reported a dividend of 1.80 USD, equaling last years dividend. The 9 analysts covering the company expect dividends of 1.80 USD for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in USD

On Oct 31, 2024, Lincoln National Corp reported 3rd quarter 2024 earnings of 2.06 per share. This result exceeded the 1.62 consensus of the 13 analysts covering the company and exceeded last year's 3rd quarter results by 1.83.
The next earnings announcement is expected on Feb 06, 2025.
Average growth rate+204.86%
Lincoln National Corp reported annual 2023 earnings of 5.22 per share on Feb 08, 2024.
Average growth rate+25.29%
More ▼

Revenue history & estimates in USD

Lincoln National Corporation had 3rd quarter 2024 revenues of 4.11bn. This missed the 4.62bn consensus estimate of the 6 analysts following the company. This was 11.72% below the prior year's 3rd quarter results.
Average growth rate+17.35%
Lincoln National Corporation had revenues for the full year 2023 of 16.03bn. This was 14.13% below the prior year's results.
Average growth rate-2.58%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.